Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Econ Entomol ; 104(4): 1323-8, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21882699

RESUMEN

Western flower thrips, Frankliniella occidentalis (Pergande) (Thysanoptera: Thripidae), is a major horticultural pest and an important vector of plant viruses in many parts of the world. Methods for assessing thrips population density for pest management decision support are often inaccurate or imprecise due to thrips' positive thigmotaxis, small size, and naturally aggregated populations. Two established methods, flower tapping and an alcohol wash, were compared with a novel method, plant desiccation coupled with passive trapping, using accuracy, precision and economic efficiency as comparative variables. Observed accuracy was statistically similar and low (37.8-53.6%) for all three methods. Flower tapping was the least expensive method, in terms of person-hours, whereas the alcohol wash method was the most expensive. Precision, expressed by relative variation, depended on location within the greenhouse, location on greenhouse benches, and the sampling week, but it was generally highest for the flower tapping and desiccation methods. Economic efficiency, expressed by relative net precision, was highest for the flower tapping method and lowest for the alcohol wash method. Advantages and disadvantages are discussed for all three methods used. If relative density assessment methods such as these can all be assumed to accurately estimate a constant proportion of absolute density, then high precision becomes the methodological goal in terms of measuring insect population density, decision making for pest management, and pesticide efficacy assessments.


Asunto(s)
Monitoreo del Ambiente/métodos , Insectos , Animales , Monitoreo del Ambiente/economía , Flores/parasitología , Densidad de Población
2.
Insects ; 11(8)2020 Aug 03.
Artículo en Inglés | MEDLINE | ID: mdl-32756374

RESUMEN

Applications of systemic pesticides can have unexpected direct and indirect effects on nontarget organisms, producing ecosystem-level impacts. We investigated whether a systemic insecticide (imidacloprid) could be absorbed by a plant pathogenic fungus infecting treated plants and whether the absorbed levels were high enough to have detrimental effects on the survival of a mycophagous beetle. Beetle larvae fed on these fungi were used to assess the survival effects of powdery mildew and imidacloprid in a factorial design. Fungal conidia were collected from treated and untreated plants and were tested for the presence and concentration of imidacloprid. The survival of beetles fed powdery mildew from imidacloprid-treated leaves was significantly lower than that of the beetles from all other treatments. Imidacloprid accumulated in fungal conidia and hyphae was detected at levels considered lethal to other insects, including coccinellid beetles. Water-soluble systemic insecticides may disrupt mycophagous insects as well as other nontarget organisms, with significant implications for biodiversity and ecosystem function.

3.
Schizophr Res ; 88(1-3): 127-34, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16926093

RESUMEN

INTRODUCTION: Some groups have reported the longitudinal course of elderly poor outcome schizophrenic patients to be characterized by progressive decline in cognitive functions and functional capacity. Although many of these patients experience minimal reduction of psychotic symptoms, there may be beneficial effects of antipsychotic treatments on cognitive functions and functional capacity. METHODS: This naturalistic study compared the longitudinal course of psychotic symptoms, cognitive functions and functional impairment in geriatric schizophrenic patients treated with first generation (N=97) or second generation (N=78) antipsychotic medications. Mixed effects linear regression analyses were used to examine the effects of treatment (first generation vs. second generation antipsychotic), time and treatment x time. RESULTS: Cognitive functions (Mini Mental State Examination time effect estimate=-.41, p<.001; ADAS-L Cog time effect estimate=.64, p<.001) and self-care skills (ADAS-L Self-Care time effect estimate=.65, p<.001) declined over time for the subject group as a whole and this decline was not modified by treatment with second generation antipsychotics relative to first generation antipsychotics. Similarly, second generation antipsychotic treatment produced no effect on the progressive worsening of negative symptom over time. CONCLUSION: This long-term naturalistic study of poor outcome geriatric patients with schizophrenia did not find atypical antipsychotics to produce any differential protective effect relative to typical antipsychotics on the long-term manifestations of symptoms, cognition and self-care in poor outcome geriatric schizophrenic patients.


Asunto(s)
Antipsicóticos/uso terapéutico , Esquizofrenia/rehabilitación , Anciano , Enfermedad Crónica , Femenino , Hospitalización/estadística & datos numéricos , Humanos , Masculino , Admisión del Paciente/estadística & datos numéricos , Estudios Retrospectivos , Autocuidado , Factores de Tiempo , Resultado del Tratamiento
4.
J Econ Entomol ; 99(4): 1168-75, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16937669

RESUMEN

The leafminer Liriomyza trifolii (Burgess) (Diptera: Agromyzidae) is a worldwide pest of ornamental and vegetable crops. The most promising nonchemical approach for controlling Liriomyza leafminers in greenhouses is regular releases of the parasitoid Diglyphus isaea (Walker) (Hymenoptera: Eulophidae). In the current study, we examine the hypothesis that the use of D. isaea for biological control of leafminers in greenhouse crops may be more practical and efficient when supplemented with additional control strategies, such as the sterile insect technique (SIT). In small cages, our SIT experiments suggest that release of sterile L. trifolii males in three sterile-to-fertile male ratios (3:1, 5:1, and 10:1) can significantly reduce the numbers of the pest offspring. In large cage experiments, when both parasitoids and sterile males were released weekly, the combined methods significantly reduced mine production and the adult leafminer population size. Moreover, a synergistic interaction effect between these two methods was found, and a model based on our observed data predicts that because of this effect, only the use of both methods can eradicate the pest population. Our study indicates that an integrated pest management approach that combines the augmentative release of the parasitoid D. isaea together with sterile leafminer males is more efficient than the use of either method alone. In addition, our results validate previous theoretical models and demonstrate synergistic control with releases of parasitoids and sterile insects.


Asunto(s)
Dípteros/fisiología , Control Biológico de Vectores/métodos , Avispas/fisiología , Animales , Dípteros/parasitología , Femenino , Fertilidad , Interacciones Huésped-Parásitos/fisiología , Infertilidad Masculina , Masculino , Conducta Sexual Animal
5.
Am J Psychiatry ; 162(4): 793-5, 2005 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15800156

RESUMEN

OBJECTIVE: This study longitudinally assessed previously validated dimensions of thought disorder--verbal underproductivity and disconnection--in geriatric schizophrenia and replicated previous cross-sectional differences in communication disorders. METHOD: Two hundred twenty patients with chronic schizophrenia were assessed with the Thought, Language, and Communication Scale over a mean follow-up period of 2.3 years. RESULTS: Patients had increases in verbal underproductivity but stable scores on disconnection over the follow-up period. Worsening in verbal underproductivity was associated with concurrent worsening in Mini-Mental State Examination scores and older age at baseline. CONCLUSIONS: Verbal underproductivity worsens with aging and is associated with cognitive worsening, although disconnected speech is relatively stable. Some geriatric patients with schizophrenia may lose the skills necessary to report symptoms, leading to the impression that their clinical status is improving.


Asunto(s)
Trastornos del Conocimiento/diagnóstico , Evaluación Geriátrica , Esquizofrenia/diagnóstico , Psicología del Esquizofrénico , Anciano , Anciano de 80 o más Años , Enfermedad Crónica , Trastornos del Conocimiento/psicología , Estudios Transversales , Femenino , Estudios de Seguimiento , Evaluación Geriátrica/estadística & datos numéricos , Humanos , Estudios Longitudinales , Masculino , Pruebas Neuropsicológicas , Escalas de Valoración Psiquiátrica , Reproducibilidad de los Resultados , Índice de Severidad de la Enfermedad , Conducta Verbal
6.
Schizophr Res ; 77(2-3): 179-87, 2005 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-15894461

RESUMEN

OBJECTIVE: To determine the frequency of depressed mood in institutionalized schizophrenia patients and its association with illness-related and functional variables. METHODS: Out of 657 institutionalized schizophrenia patients, patients with depressed mood were identified and compared to non-depressed patients, matching for potential confounders. RESULTS: Forty-eight (7.3%) patients had moderate to severe depressed mood. They were younger, more educated and had fewer years since their first hospitalization than non-depressed patients. After matching for these variables, depressed patients showed more positive symptoms and exhibited better social and cognitive functioning. When controlling for negative symptoms, the differences in social and cognitive functioning between the depressed and non-depressed patients disappeared, and depressed patients showed more positive symptoms and more impaired impulse control. CONCLUSIONS: Unlike the negative impact of depressed mood in other populations, this study shows that symptoms of depressed mood may identify a subgroup of institutionalized schizophrenia patients who show better functioning across a variety of indicators. Future studies should determine differential treatment responses and long-term outcomes of these patients.


Asunto(s)
Trastornos del Conocimiento/epidemiología , Trastorno Depresivo/epidemiología , Esquizofrenia/epidemiología , Autocuidado , Ajuste Social , Adulto , Anciano , Anciano de 80 o más Años , Análisis de Varianza , Estudios de Casos y Controles , Trastornos del Conocimiento/etiología , Comorbilidad , Estudios Transversales , Trastorno Depresivo/psicología , Femenino , Humanos , Institucionalización/estadística & datos numéricos , Masculino , Persona de Mediana Edad , Prevalencia , Factores de Riesgo , Psicología del Esquizofrénico , Estados Unidos/epidemiología
7.
PLoS One ; 10(4): e0118785, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25875026

RESUMEN

It has been suggested that the ecological impact of crickets as a source of dietary protein is less than conventional forms of livestock due to their comparatively efficient feed conversion and ability to consume organic side-streams. This study measured the biomass output and feed conversion ratios of house crickets (Acheta domesticus) reared on diets that varied in quality, ranging from grain-based to highly cellulosic diets. The measurements were made at a much greater population scale and density than any previously reported in the scientific literature. The biomass accumulation was strongly influenced by the quality of the diet (p<0.001), with the nitrogen (N) content, the ratio of N to acid detergent fiber (ADF) content, and the crude fat (CF) content (y=N/ADF+CF) explaining most of the variability between feed treatments (p = 0.02; R2 = 0.96). In addition, for populations of crickets that were able to survive to a harvestable size, the feed conversion ratios measured were higher (less efficient) than those reported from studies conducted at smaller scales and lower population densities. Compared to the industrial-scale production of chickens, crickets fed a poultry feed diet showed little improvement in protein conversion efficiency, a key metric in determining the ecological footprint of grain-based livestock protein. Crickets fed the solid filtrate from food waste processed at an industrial scale via enzymatic digestion were able to reach a harvestable size and achieve feed and protein efficiencies similar to that of chickens. However, crickets fed minimally-processed, municipal-scale food waste and diets composed largely of straw experienced >99% mortality without reaching a harvestable size. Therefore, the potential for A. domesticus to sustainably supplement the global protein supply, beyond what is currently produced via grain-fed chickens, will depend on capturing regionally scalable organic side-streams of relatively high-quality that are not currently being used for livestock production.


Asunto(s)
Alimentación Animal , Pollos/fisiología , Proteínas en la Dieta , Gryllidae , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Pollos/crecimiento & desarrollo , Grano Comestible , Aves de Corral
8.
Biol Psychiatry ; 51(5): 349-57, 2002 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-11904128

RESUMEN

BACKGROUND: Despite the beneficial effects of atypical antipsychotics on cognition, these improvements will not return most schizophrenic patients to normative standards of cognitive functioning. Therefore, other treatments need to be considered. Subtle changes in cholinergic function in schizophrenic patients provide the rationale to test the effectiveness of cholinesterase inhibitors in treating cognitive impairment in schizophrenia. METHODS: Given this, a 12-week, double-blind, placebo-controlled trial of donepezil (5 mg and 10 mg) as adjunctive treatment to risperidone was conducted in a total of 36 schizophrenic patients. RESULTS: Neither the 5-mg nor 10-mg dose of donepezil produced significant improvements in any cognitive measure compared with placebo. CONCLUSIONS: It is possible that nicotinic receptor desensitization produced by chronic tobacco use in these patients rendered their nicotinic receptors refractory to the effects of increased agonist activity produced by donepezil. An alternative treatment is the allosterically potentiating ligands, which enhance the activity of (sensitize) nicotinic receptors in the presence of acetylcholine.


Asunto(s)
Antipsicóticos/administración & dosificación , Trastornos del Conocimiento/tratamiento farmacológico , Indanos/administración & dosificación , Piperidinas/administración & dosificación , Risperidona/administración & dosificación , Esquizofrenia/tratamiento farmacológico , Psicología del Esquizofrénico , Adulto , Anciano , Antipsicóticos/efectos adversos , Trastornos del Conocimiento/diagnóstico , Trastornos del Conocimiento/psicología , Donepezilo , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Quimioterapia Combinada , Femenino , Humanos , Indanos/efectos adversos , Masculino , Persona de Mediana Edad , Pruebas Neuropsicológicas , Piperidinas/efectos adversos , Risperidona/efectos adversos , Esquizofrenia/diagnóstico
9.
Am J Psychiatry ; 159(8): 1388-94, 2002 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12153833

RESUMEN

OBJECTIVE: Impairment in basic self-care skills is common in patients with schizophrenia and is even more severe in elderly patients with a chronic course of institutional care. While cognitive impairment has proven to be a major predictor of overall functional deficit in schizophrenia, other potential factors, such as medical comorbidity, need to be considered. METHOD: Geriatric institutionalized schizophrenic patients (N=124) were assessed three times over 4 years to determine levels of positive and negative symptoms, impairment in activities of daily living, impairment in cognitive functioning, and medical problems. Path analysis was used to determine which variables best predicted changes in self-care functions. RESULTS: Functional status, negative symptoms, cognitive functions, and health status all significantly worsened during the follow-up. The path analyses showed that change in health status did not predict change in activities of daily living after the analysis accounted for negative symptoms and cognitive functions. DISCUSSION: The results highlight the relative importance of cognitive impairments in the functional impairments of older schizophrenic patients with increased medical burden.


Asunto(s)
Actividades Cotidianas/clasificación , Trastornos del Conocimiento/diagnóstico , Evaluación Geriátrica , Esquizofrenia/diagnóstico , Psicología del Esquizofrénico , Actividades Cotidianas/psicología , Anciano , Enfermedad Crónica , Trastornos del Conocimiento/epidemiología , Comorbilidad , Progresión de la Enfermedad , Femenino , Estudios de Seguimiento , Estado de Salud , Humanos , Institucionalización/estadística & datos numéricos , Masculino , Morbilidad , Pruebas Neuropsicológicas , Escalas de Valoración Psiquiátrica/estadística & datos numéricos , Esquizofrenia/epidemiología , Autocuidado/psicología , Autocuidado/estadística & datos numéricos
10.
Ecol Appl ; 2(2): 139-146, 1992 May.
Artículo en Inglés | MEDLINE | ID: mdl-27759209

RESUMEN

The effect of foliage feeding by the serpentine leafminer, Liriomyza trifolii (Burgess), on seed production and germination by male-sterile marigolds (Tagetes erecta L.) was examined over two cropping seasons in commercial production greenhouses. Five components of T. erecta relative fitness (the number of flowers, ovules, and germinations per plant, seed mass, and plant height) were compared in plants grown under four different control strategies representing three different intensities of L. trifolii herbivory: no control (high herbivory), biological or chemical control (intermediate herbivory), and insect-free (low herbivory). In both years of the study, significant between-treatment differences in number of viable seeds per plant were detected but no significant differences were found in the other four relative fitness measures. The number of viable seeds was highest with high herbivory (no-control treatments) and lowest with comparatively low herbivory (chemical and insect-free treatments). L. trifolii damage may reduce photosynthate availability, which may slow seed development and increase the length of time in which ovule physiological and morphological conditions are suitable for successful fertilization. Because all plants within each year received an equal number of pollinations occurring at the same time relative to plant growth, ovules within plants in the high-damage treatments may have had a greater probability of being fertilized, resulting in an increase in production of viable seeds.

11.
Arch Clin Neuropsychol ; 17(7): 611-23, 2002 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-14591846

RESUMEN

There is evidence that some elderly patients with chronic schizophrenia experience marked impairments in cognitive functioning. Assessment of these patients may be difficult with traditional neuropsychological measures. The purpose of the present study was to determine if cognitive functioning could be validly assessed with the Alzheimer's Disease Assessment Scale-Late Version Cognitive factor score (ADAS-L Cog) in patients whose scores on the Mini-Mental State Examination (MMSE) reflect profound cognitive impairment. Patients with MMSE scores from 0 to 10 were selected from a larger database. Neuropsychological instruments designed for the assessment of mild to moderate dementia were found to be inadequate in this profoundly impaired population, due to floor effects. In contrast, there was a significant relationship between ADAS-L scores and several criterion measures, including the MMSE (R=-.71, P<.001), the Social Adaptive Functions Evaluation (SAFE) social functions scale (R=.47, P<.001), and the negative symptom total score of the Positive and Negative Syndrome Scale (PANSS) (R=.412, P<.001). The MMSE was somewhat less strongly correlated with both social functions (R=-.401, P<.001) and the negative symptom total score of the PANSS (R=-.366, P<.001). These results suggest that cognition can be reliably and validly assessed with instruments such as the ADAS-L that are designed for the assessment of severely impaired patients.

12.
Schizophr Res ; 130(1-3): 94-100, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21641187

RESUMEN

Recently, the negative effects of hypertension and elevated body mass index on cognitive functioning in schizophrenia have been reported (Friedman et al., 2010). Data suggests that cognitive changes in hypertensive patients from the general population may be mediated, in part, by white matter damage. Therefore, we performed diffusion tensor imaging (DTI) in the same subjects studied by Friedman et al. (2010) to investigate the effects of hypertension and elevated body mass index on the fractional anisotropy (FA) of several major white matter tracts. Significant interactions between a diagnosis of schizophrenia and hypertension on FA in several white matter regions were detected. Hypertension was associated with lower FA in the schizophrenic group and higher FA in the same tracts in the non-schizophrenic subjects. These results suggest hypertension-induced compensatory mechanisms in the brains of non-schizophrenic patients with hypertension which may be impaired in persons with schizophrenia.


Asunto(s)
Índice de Masa Corporal , Encéfalo/patología , Hipertensión/complicaciones , Esquizofrenia/complicaciones , Esquizofrenia/patología , Adulto , Anciano , Anisotropía , Mapeo Encefálico , Imagen de Difusión Tensora/métodos , Femenino , Humanos , Hipertensión/patología , Procesamiento de Imagen Asistido por Computador , Masculino , Persona de Mediana Edad , Escalas de Valoración Psiquiátrica , Factores de Riesgo
13.
Neuropsychopharmacology ; 36(6): 1289-95, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21346734

RESUMEN

Despite its superior efficacy, clozapine is helpful in only a subset of patients with schizophrenia unresponsive to other antipsychotics. This lack of complete success has prompted the frequent use of various clozapine combination strategies despite a paucity of evidence from randomized controlled trials supporting their efficacy. Pimozide, a diphenylbutylpiperidine, possesses pharmacological and clinical properties distinct from other typical antipsychotics. An open-label trial of pimozide adjunctive treatment to clozapine provided promising pilot data in support of a larger controlled trial. Therefore, we conducted a double-blind, placebo-controlled, parallel-designed 12-week trial of pimozide adjunctive treatment added to ongoing optimal clozapine treatment in 53 patients with schizophrenia and schizoaffective disorder partially or completely unresponsive to clozapine monotherapy. An average dose of 6.48 mg/day of pimozide was found to be no better than placebo in combination with clozapine at reducing Positive and Negative Syndrome Scale total, positive, negative, and general psychopathology scores. There is no suggestion from this rigorously conducted trial to suggest that pimozide is an effective augmenting agent if an optimal clozapine trial is ineffective. However, given the lack of evidence to guide clinicians and patients when clozapine does not work well, more controlled trials of innovative strategies are warranted.


Asunto(s)
Encéfalo/efectos de los fármacos , Clozapina/agonistas , Pimozida/administración & dosificación , Trastornos Psicóticos/tratamiento farmacológico , Esquizofrenia/tratamiento farmacológico , Adulto , Antipsicóticos/agonistas , Encéfalo/fisiopatología , Método Doble Ciego , Resistencia a Medicamentos/efectos de los fármacos , Resistencia a Medicamentos/fisiología , Sinergismo Farmacológico , Quimioterapia Combinada/métodos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Placebos
14.
Am J Psychiatry ; 167(10): 1232-9, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20634363

RESUMEN

OBJECTIVE: In recent years there has been a greater appreciation of the elevated prevalence of cardiovascular risk factors in the schizophrenia population and the liability some treatments have for their development. These vascular risk factors are in turn important risk factors in the development of dementia and more subtle cognitive impairments. However, their impact on the cognitive functions of patients with schizophrenia remains underexplored. The authors investigated whether vascular risk factors influence the cognitive impairments of schizophrenia and whether their effects on cognition in schizophrenia are different from those observed in nonpsychiatric comparison subjects. METHOD: The authors compared 100 patients with schizophrenia and 53 comparison subjects on cognitive test performance in 2×2 matrices composed of individual vascular risk factors and group (schizophrenia patients and comparison subjects). RESULTS: Hypertension exerted a significant negative effect on immediate delayed and recognition memory in both groups. Patients with schizophrenia and hypertension were adversely affected in recognition memory, whereas comparison subjects were not. A body mass index above 25 was associated with negative effects on delayed memory in both groups, although the association fell short of statistical significance. CONCLUSIONS: Given that patients with schizophrenia have a higher prevalence of vascular risk factors than the general population and are undertreated for them, treatment of these risk factors may significantly improve cognitive outcome in schizophrenia.


Asunto(s)
Trastornos del Conocimiento/diagnóstico , Hipertensión/epidemiología , Sobrepeso/epidemiología , Esquizofrenia/diagnóstico , Adulto , Índice de Masa Corporal , Enfermedades Cardiovasculares/diagnóstico , Enfermedades Cardiovasculares/epidemiología , Trastornos del Conocimiento/epidemiología , Comorbilidad , Femenino , Humanos , Hipertensión/diagnóstico , Masculino , Trastornos de la Memoria/diagnóstico , Trastornos de la Memoria/epidemiología , Persona de Mediana Edad , Pruebas Neuropsicológicas , Sobrepeso/diagnóstico , Prevalencia , Factores de Riesgo , Esquizofrenia/epidemiología , Psicología del Esquizofrénico
15.
J Clin Psychopharmacol ; 28(1): 59-63, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18204342

RESUMEN

Relationships between altered prefrontal cortical dopamine, norepinephrine, and some of the cognitive impairments of schizophrenia support an approach for pharmacological remediation of cognitive symptoms through manipulations of prefrontal cortical dopamine and norepinephrine. Atomoxetine, a selective norepinephrine reuptake inhibitor, produces a widespread increase in brain norepinephrine and a secondary and selective increase in prefrontal dopamine. Given this, we evaluated atomoxetine's cognitive effects in a pilot placebo-controlled trial in patients with schizophrenia. Moreover, a functional magnetic resonance imaging investigation was undertaken to assess the neural mechanisms underlying the cognitive effects of atomoxetine. Twenty participants with schizophrenia were randomized to treatment with placebo or atomoxetine 80 mg daily for an 8-week parallel-designed treatment trial. Cognitive performance was assessed with the Brief Assessment of Cognition in Schizophrenia. No significant cognitive improvement was associated with atomoxetine treatment. However, atomoxetine treatment was associated with significantly greater increases in working memory-related activation of the left dorsolateral prefrontal and left posterior cingulate cortices. The negative results of this study conflict with the effectiveness of amphetamine in enhancing the cognitive abilities of schizophrenic patients and may be related to the differential pattern of cortical activation and deactivation produced by amphetamine.


Asunto(s)
Inhibidores de Captación Adrenérgica/administración & dosificación , Antipsicóticos/uso terapéutico , Trastornos del Conocimiento/tratamiento farmacológico , Propilaminas/administración & dosificación , Esquizofrenia/tratamiento farmacológico , Psicología del Esquizofrénico , Inhibidores de Captación Adrenérgica/uso terapéutico , Clorhidrato de Atomoxetina , Relación Dosis-Respuesta a Droga , Quimioterapia Combinada , Humanos , Imagen por Resonancia Magnética , Proyectos Piloto , Propilaminas/uso terapéutico
16.
J Clin Exp Neuropsychol ; 28(2): 178-92, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16484092

RESUMEN

This paper presents the results of two studies of the validity of word-recognition reading as an indicator of premorbid functioning in schizophrenia. The first examined the stability over a 6-year follow-up period of word recognition reading compared to other aspects of cognitive functioning, including verbal learning and delayed recall, verbal fluency, constructional skills, and naming ability. The second study examined the relative predictive power of indicators of premorbid functioning as compared to current cognitive functioning for the prediction of current social and self-care skills. In the first study 218 patients with chronic schizophrenia participated. For the second study, 231 male veterans with schizophrenia were assessed for cognitive functioning, indicators of premorbid adjustment, and current functional status. Analyses of the differences between correlations indicated that word recognition reading ability was significantly more stable than other aspects of cognitive functioning over a six-year period during which decline in some other aspects of performance was found. In the second study, premorbid educational and social attainment, word recognition reading skill, and current cognitive functioning were all significantly related to current functional status, defined by correlations with ratings of current functional status. Path analyses indicated, however, that current cognitive functioning was the only significant predictor of current functional status when the intercorrelations of the variables were considered. In sum, Premorbid functioning estimated with word-recognition reading was stable over time (study 1) and correlated with both current cognitive and functional status (study 2). The results of these two studies suggest that word-recognition reading skills are useful screening instruments to estimate premorbid functioning even in deteriorated patients with schizophrenia.


Asunto(s)
Logro , Trastornos del Conocimiento/diagnóstico , Trastornos del Conocimiento/epidemiología , Esquizofrenia/epidemiología , Adulto , Anciano , Evaluación Educacional , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Lectura , Índice de Severidad de la Enfermedad
17.
Plant J ; 43(1): 79-96, 2005 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15960618

RESUMEN

Glucosinolates are a class of secondary metabolites with important roles in plant defense and human nutrition. To uncover regulatory mechanisms of glucosinolate production, we screened Arabidopsis thaliana T-DNA activation-tagged lines and identified a high-glucosinolate mutant caused by overexpression of IQD1 (At3g09710). A series of gain- and loss-of-function IQD1 alleles in different accessions correlates with increased and decreased glucosinolate levels, respectively. IQD1 encodes a novel protein that contains putative nuclear localization signals and several motifs known to mediate calmodulin binding, which are arranged in a plant-specific segment of 67 amino acids, called the IQ67 domain. We demonstrate that an IQD1-GFP fusion protein is targeted to the cell nucleus and that recombinant IQD1 binds to calmodulin in a Ca(2+)-dependent fashion. Analysis of steady-state messenger RNA levels of glucosinolate pathway genes indicates that IQD1 affects expression of multiple genes with roles in glucosinolate metabolism. Histochemical analysis of tissue-specific IQD1::GUS expression reveals IQD1 promoter activity mainly in vascular tissues of all organs, consistent with the expression patterns of several glucosinolate-related genes. Interestingly, overexpression of IQD1 reduces insect herbivory, which we demonstrated in dual-choice assays with the generalist phloem-feeding green peach aphid (Myzus persicae), and in weight-gain assays with the cabbage looper (Trichoplusia ni), a generalist-chewing lepidopteran. As IQD1 is induced by mechanical stimuli, we propose IQD1 to be novel nuclear factor that integrates intracellular Ca(2+) signals to fine-tune glucosinolate accumulation in response to biotic challenge.


Asunto(s)
Proteínas de Arabidopsis/fisiología , Arabidopsis/metabolismo , Proteínas de Unión a Calmodulina/fisiología , Glucosinolatos/biosíntesis , Secuencia de Aminoácidos , Animales , Áfidos , Señalización del Calcio , Calmodulina/metabolismo , Conducta Alimentaria , Regulación de la Expresión Génica de las Plantas , Datos de Secuencia Molecular , Unión Proteica , Alineación de Secuencia , Homología de Secuencia de Aminoácido , Distribución Tisular
18.
J Clin Psychopharmacol ; 25(3): 237-42, 2005 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15876902

RESUMEN

Cognitive enhancement in patients with schizophrenia is a major treatment priority. Because serotonergic approaches have been suggested as a possible mechanism to enhance cognition and many patients with schizophrenia are treated with selective serotonin reuptake inhibitor antidepressants, we evaluated a serotonin reuptake inhibitor, citalopram, as adjunctive therapy to atypical antipsychotic treatment for its cognitive enhancing effects in schizophrenic patients. Nineteen schizophrenic patients were treated in a randomized, placebo-controlled, crossover-designed 24-week study. In phase 1, subjects were randomized equally to 40 mg of citalopram or placebo and were evaluated prior to initiation of pharmacotherapy and at the end of phase 1 (after 12 weeks of treatment with double-blind agent). At the beginning of phase 2, subjects were crossed over to the other treatment and subsequently assessed after 12 weeks of treatment for symptom severity and cognitive performance. There were no statistically significant differences between citalopram 40 mg/d and placebo treatment on any clinical or cognitive measures. These results indicate that citalopram adjunctive treatment to atypical antipsychotics produces no significant cognitive improvement in patients with schizophrenia. Because the subjects in this study were all treated with atypical antipsychotics, it is possible that the pharmacologic profiles of atypical antipsychotic medications at serotonin receptors may have complicated the effects of citalopram augmentation. Further research on alternative serotonergic approaches to cognitive enhancement in schizophrenia is warranted.


Asunto(s)
Antipsicóticos/administración & dosificación , Citalopram/administración & dosificación , Cognición/efectos de los fármacos , Esquizofrenia/tratamiento farmacológico , Psicología del Esquizofrénico , Adulto , Análisis de Varianza , Cognición/fisiología , Estudios Cruzados , Método Doble Ciego , Quimioterapia Combinada , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pruebas Neuropsicológicas/estadística & datos numéricos
19.
J Nerv Ment Dis ; 192(12): 880-3, 2004 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-15583513

RESUMEN

Three hundred thirty-three elderly schizophrenic inpatients were rated on the Positive and Negative Syndrome Scale (PANSS), and those remaining in the hospital after 1 year (N = 267) were rated and followed for an additional year. Based on previous studies showing that aggressive episodes and hostile behavior predicted inability to discharge schizophrenics, we hypothesized that low discharge rates would be correlated with high baseline ratings on the activation factor of the PANSS (PANSS-AF), obtained by summing six items (hostility, poor impulse control, excitement, uncooperativeness, poor rapport, and tension). Baseline PANSS-AF scores were found to be inversely correlated with discharge rates, independent of ratings on other symptom dimensions. PANSS-AF scores were a better predictor of outcome than any individual PANSS item (e.g., hostility), and individual item scores did not add significantly to prediction of discharge. Attention to and development of treatments for activation symptoms, highly prevalent in schizophrenia but not included in our present diagnostic systems, may increase the chances of elderly inpatients with schizophrenia of moving to community settings.


Asunto(s)
Hospitalización , Alta del Paciente/estadística & datos numéricos , Escalas de Valoración Psiquiátrica/estadística & datos numéricos , Esquizofrenia/diagnóstico , Psicología del Esquizofrénico , Escalas de Valoración Psiquiátrica Breve/estadística & datos numéricos , Enfermedad Crónica , Servicios Comunitarios de Salud Mental , Análisis Factorial , Estudios de Seguimiento , Psiquiatría Geriátrica , Hospitales Provinciales/estadística & datos numéricos , Hostilidad , Humanos , Modelos Lineales , Valor Predictivo de las Pruebas , Agitación Psicomotora/diagnóstico , Reproducibilidad de los Resultados , Esquizofrenia/terapia
20.
Am J Geriatr Psychiatry ; 12(4): 376-86, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15249275

RESUMEN

OBJECTIVE: There is an increasing interest in the usefulness of neurocognitive subtyping of schizophrenia. The classification of schizophrenia patients with cortical versus subcortical impairments has recently been validated with both neuropsychological and neurobiological measures. The authors examined the stability and correlations of these classifications with longitudinal assessments in older, chronically ill schizophrenia patients. METHODS: Older, chronically ill patients (N=589) were classified on the basis of their baseline profile, and a subset (N=243) was followed for periods up to 8 years, with data analyses conducted to evaluate the stability of these profiles, to determine whether classification into cortical or subcortical impairment at baseline predicts changes in self-care and social functioning at endpoint, up to 8 years later. RESULTS: Cortical profiles were most common and most stable over time, with the majority of patients with a subcortical profile at baseline found to have a cortical profile at follow-up. Those patients whose subcortical impairment profile was stable over time had less severe cognitive and functional impairments at baseline than those whose profile was found to be cortical at follow-up. DISCUSSION: Cortical profiles of memory impairment were associated with substantial cognitive impairments at baseline and did not predict risk for subsequent cognitive decline, whereas subcortical profiles were associated with worsening of cognitive impairments in about half of the cases. Those patients with more severe negative symptoms and cognitive and functional impairments within the subcortical group were most likely to decline.


Asunto(s)
Encéfalo/fisiopatología , Trastornos de la Memoria , Esquizofrenia/complicaciones , Esquizofrenia/fisiopatología , Anciano , Femenino , Estudios de Seguimiento , Humanos , Masculino , Trastornos de la Memoria/clasificación , Trastornos de la Memoria/diagnóstico , Trastornos de la Memoria/etiología , Persona de Mediana Edad , Pruebas Neuropsicológicas , Índice de Severidad de la Enfermedad , Conducta Social
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA